This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Aptar Digital Health, a developer of Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs), and disease management solutions, has announced a new partnership with Legit.Health, an artificial intelligence-based, medical device software company that focuses on the early detection, evaluation, and monitoring of skin diseases.
Legit.Health’s technology, which supports the diagnosis of approximately 300 conditions including atopic dermatitis, psoriasis, and skin cancer, will be integrated into Aptar's Digital Health proprietary platform. Focused on enhancing patient care and increasing patient autonomy, this advanced digital solution will support healthcare professionals (HCPs) to diagnose skin conditions earlier and will enable patients to start treatment plans sooner to improve their overall quality of life. The solution also may be used to facilitate patient enrollment in clinical trials.
Legit.Health's use of AI for monitoring disease progression through automated, clinically validated scoring systems, such as the Psoriasis Area Severity Index (PASI) and SCORing Atopic Dermatitis (SCORAD), will be leveraged within this partnership. This will help to ensure patients receive the most accurate and timely information to manage and treat their skin condition more effectively. The AI-powered technology also extends to the quantification of the intensity, count, and extent of the visible clinical signs of skin conditions, offering HCPs a more precise measure of disease severity, an indicator considered critical in determining the most appropriate treatment.
This strategic partnership is set to drive digital transformation in the healthcare sector. Aptar Digital Health and Legit.Health together will pave the way towards harnessing the power of AI to improve patient experiences and outcomes in immuno-dermatology.
Sai Shankar, President, Aptar Digital Health, stated, “Since 2021, Aptar Digital Health has been growing our portfolio of technology partners to provide improved solutions for patients in multiple therapeutic areas such as cardiology, neurology and visual acuity. With this new partnership, Aptar Digital Health is acquiring the ability to leverage AI technology to accelerate the diagnosis and monitoring of skin conditions.”
Andy Aguilar, CEO and Co-Founder of Legit.Health, commented, “One of our main aims within the medical assistance process in the field of dermatology is to be able to offer patients the opportunity of having the earliest and most accurate diagnosis, with the appropriate referral and treatment to reduce uncertainty and waiting times.” She added, “Legit.Health's technology helps the medical practitioner to provide this kind of care to their patients and today, thanks to our partnership with Aptar Digital Health, we will be able to reach even more people who will benefit from our service
